Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.46
24.01.24
-
24.01.25
-11.64%
21.03.24

StockNews.com 
24.01.24 50%
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€24.80
24.01.24
€33.86
24.01.25
-46.49%
27.09.24

Needham & Company LLC 
24.01.24 50%
sell
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€401.90
24.01.24
€346.79
24.01.25
3.20%
04.10.24

Canaccord Genuity Group Inc. 
24.01.24 50%
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€3.46
24.01.24
€12.81
24.01.25
85.98%
17.09.24

Needham & Company LLC 
24.01.24 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€581.50
23.01.24
€581.49
23.01.25
39.52%
04.10.24

Cantor Fitzgerald 
23.01.24 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€147.50
23.01.24
€198.45
23.01.25
1.28%
04.10.24

Cantor Fitzgerald 
23.01.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€873.50
23.01.24
€938.09
23.01.25
5.60%
04.10.24

Barclays PLC 
23.01.24 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€129.15
23.01.24
€137.96
23.01.25
-19.51%
04.10.24

Barclays PLC 
23.01.24 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€108.20
23.01.24
€124.16
23.01.25
-5.62%
04.10.24

Barclays PLC 
23.01.24 50%
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€15.15
23.01.24
-
23.01.25
33.60%
04.10.24

StockNews.com 
23.01.24 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€580.50
23.01.24
€625.12
23.01.25
39.76%
04.10.24

Barclays PLC 
23.01.24 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€151.90
23.01.24
€160.88
23.01.25
17.47%
04.10.24

Barclays PLC 
23.01.24 50%
buy
Cara Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.51
22.01.24
€4.59
22.01.25
-51.45%
04.10.24

Needham & Company LLC 
22.01.24 50%
buy
Xencor Inc.

Start price
Target price
Perf. (%)
€18.20
22.01.24
€45.89
22.01.25
-4.40%
03.10.24

Mizuho 
22.01.24 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€75.50
22.01.24
€94.52
22.01.25
-31.13%
04.10.24

Mizuho 
22.01.24 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€21.60
22.01.24
€32.12
22.01.25
-65.57%
03.10.24

JPMorgan Chase & Co. 
22.01.24 50%
sell
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€0.69
21.01.24
-
21.01.25
-50.72%
31.07.24

StockNews.com 
21.01.24 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€126.90
20.01.24
-
20.01.25
-18.09%
04.10.24

StockNews.com 
20.01.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€31.35
19.01.24
€45.94
19.01.25
72.06%
04.10.24

Benchmark Co. 
19.01.24 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€40.20
19.01.24
€104.83
19.01.25
21.89%
03.10.24

Cantor Fitzgerald 
19.01.24 50%
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.40
19.01.24
€2.76
19.01.25
78.90%
04.10.24

HC Wainwright 
19.01.24 50%
buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€46.60
18.01.24
€57.10
18.01.25
-25.90%
04.10.24

Piper Sandler 
18.01.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€31.43
18.01.24
€44.22
18.01.25
71.62%
04.10.24

HC Wainwright 
18.01.24 50%
buy
Medpace Holdings Inc

Start price
Target price
Perf. (%)
€262.00
17.01.24
€286.92
17.01.25
19.31%
04.10.24

Robert W. Baird 
17.01.24 50%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€174.40
17.01.24
€208.24
17.01.25
-0.30%
04.10.24

The Goldman Sachs Group, Inc. 
17.01.24 50%